Urokinase Receptor and Resistance to Targeted Anticancer Agents
The urokinase receptor/uPAR is a GPI-anchored membrane protein, which regulates protease activity at the cell surface and, in collaboration with a system of co-receptors, triggers cell-signaling and regulates gene expression within the cell. In normal tissues, uPAR gene expression is limited; howeve...
Saved in:
Main Authors: | Steven L. Gonias (Author), Jingjing eHu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2015-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
by: Ran Zhu, et al.
Published: (2022) -
Serum Soluble Urokinase Plasminogen Activator Receptor Levels in Resistant Hypertension
by: Nergiz Bayrakcı, et al.
Published: (2024) -
Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs
by: Yu-Ching Chang, et al.
Published: (2023) -
Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
by: Dimitrios Velissaris, et al.
Published: (2022) -
Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects
by: Mohamed Abd‑Ellatif El‑Patal, et al.
Published: (2022)